Form 8-K - Current report:
SEC Accession No. 0001585364-24-000116
Filing Date
2024-08-09
Accepted
2024-08-08 18:47:35
Documents
19
Period of Report
2024-08-06
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K prgo-20240806.htm   iXBRL 8-K 35145
2 EX-99.1 perrigoinfantformulareca.htm EX-99.1 4271
7 perrigoinfantformulareca001.jpg GRAPHIC 185913
8 perrigoinfantformulareca002.jpg GRAPHIC 79216
9 perrigoinfantformulareca003.jpg GRAPHIC 79170
10 perrigoinfantformulareca004.jpg GRAPHIC 85170
  Complete submission text file 0001585364-24-000116.txt   827567

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20240806.xsd EX-101.SCH 3880
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prgo-20240806_def.xml EX-101.DEF 8180
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20240806_lab.xml EX-101.LAB 33648
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20240806_pre.xml EX-101.PRE 20215
22 EXTRACTED XBRL INSTANCE DOCUMENT prgo-20240806_htm.xml XML 7031
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 241189982
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)